echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Peptide News > Gut protein is associated with the risk of HIV infection

    Gut protein is associated with the risk of HIV infection

    • Last Update: 2018-01-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, scientists have found for the first time that the key immune cells that express the intestinal "homing" protein a4b7 highly during HIV infection have an impact on the health of patients   In this study, the authors found that women with higher levels of a4b7 expression and more CD4 T cells had a higher risk of HIV infection and a faster rate of virus damage to the immune system The results were published in the latest issue of Science Translational Medicine   The authors first compared the proportion of subsets with high expression of a4b7 protein in CD4 T cells in 59 patients before HIV infection and 106 healthy people The results showed that the proportion of CD4 T cells with high expression of a4b7 affected the risk of HIV infection to some extent Specifically, for every 1% increase in the number of cells in this subgroup, the risk of HIV will increase by about 18%   In addition, the proportion of a4b7 protein overexpression subpopulation cells will also affect the rate of HIV damage the immune system (nearly twice) The molecular mechanism may be related to the destruction of intestinal homeostasis by HIV, because the researchers found that the high level of a4b7 expression was accompanied by the increase of intestinal damage biomarker level   The researchers found that HIV can target and recognize CD4 T cells with high expression of a4b7 protein in the early stage of infection, while art in the early stage of infection does not prevent the loss of CD4 T cells or promote the reconstruction of damaged cells   "These findings suggest that we need interventions other than art to restore the number of CD4 T cells in the gut of people with HIV," said Dr McKinnon "One way is to target the antibody vedolizumab of a4b7, which has been approved by the FDA for the treatment of ulcerative enteritis and Crohn's disease.".
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.